Related Experiment Video
Updated: Oct 2, 2025

Characterization of Human Monocyte Subsets by Whole Blood Flow Cytometry Analysis
Published on: October 17, 2018
Phenotypic and Functional Heterogeneity of Monocyte Subsets in Chronic Heart Failure Patients
Aušra Mongirdienė1, Julius Liobikas2
1Department of Biochemistry, Medical Academy, Lithuanian University of Health Sciences, LT50161 Kaunas, Lithuania.
Insights
Inflammation plays a key role in chronic heart failure (CHF). This study explores how different monocyte subsets contribute to heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF).
Area of Science:
- Cardiovascular Medicine
- Immunology
- Cell Biology
Background:
- Chronic heart failure (CHF) impairs the heart's ability to supply oxygen and nutrients.
- Inflammation is a key factor in the pathogenesis of both HFpEF and HFrEF.
- Monocytes, immune cells, are involved in cardiovascular injury response and inflammation.
Purpose of the Study:
- To summarize current research on monocyte subset functions in CHF.
- To focus on the role of specific monocyte subsets in HFpEF and HFrEF patients.
- To examine the relationship between monocyte subsets and inflammatory markers in CHF.
Main Methods:
- Literature review of studies on monocyte subsets in cardiovascular disease.
- Analysis of monocyte heterogeneity and function in different heart failure types.
- Correlation of monocyte subset activity with inflammatory markers.
Main Results:
- Monocytes are not homogenous and exhibit diverse functions in cardiovascular disease.
- Specific monocyte subsets play distinct roles in HFpEF and HFrEF.
- Monocyte subset activity is linked to inflammatory processes in CHF.
Conclusions:
- Monocyte subsets are critical cellular mediators in CHF pathogenesis.
- Understanding monocyte subset roles is vital for differentiating HFpEF and HFrEF.
- Further research is needed to clarify whether monocyte functions are causes or consequences in CHF development.
Abstract:
Chronic heart failure (CHF) results when the heart cannot consistently supply the body's tissues with oxygen and required nutrients. CHF can be categorized as heart failure (HF) with preserved ejection fraction (HFpEF) or HF with reduced ejection fraction (HFrEF). There are different causes and mechanisms underlying HF pathogenesis; however, inflammation can be regarded as one of the factors that promotes both HFrEF and HFpEF. Monocytes, a subgroup of leukocytes, are known to be cellular mediators in response to cardiovascular injury and are closely related to inflammatory reactions. These cells are a vital component of the immune system and are the source of macrophages, which participate in cardiac tissue repair after injury. However, these monocytes are not as homogenous as thought and can present different functions under different cardiovascular disease conditions. In addition, there is still an open question regarding whether the functions of monocytes and macrophages should be regarded as causes or consequences in CHF development. Therefore, the aim of this work was to summarize current studies on the functions of various monocyte subsets in CHF with a focus on the role of a certain monocyte subset in HFpEF and HFrEF patients, as well as the subsets' relationship to inflammatory markers.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

